TAVR and cancer: machine learning-augmented propensity score mortality and cost analysis in over 30 million patients.

MLA

Monlezun, Dominique J., et al. “TAVR and Cancer: Machine Learning-Augmented Propensity Score Mortality and Cost Analysis in over 30 Million Patients.” Cardio-Oncology (London, England), vol. 7, no. 1, June 2021, p. 25. EBSCOhost, https://doi.org/10.1186/s40959-021-00111-0.

APA

Monlezun, D. J., Hostetter, L., Balan, P., Palaskas, N., Lopez-Mattei, J., Cilingiroglu, M., Iakobishvili, Z., Ewer, M., Marmagkiolis, K., & Iliescu, C. (2021). TAVR and cancer: machine learning-augmented propensity score mortality and cost analysis in over 30 million patients. Cardio-Oncology (London, England), 7(1), 25. https://doi.org/10.1186/s40959-021-00111-0

Chicago

Monlezun, Dominique J, Logan Hostetter, Prakash Balan, Nicolas Palaskas, Juan Lopez-Mattei, Mehmet Cilingiroglu, Zaza Iakobishvili, Michael Ewer, Konstantinos Marmagkiolis, and Cezar Iliescu. 2021. “TAVR and Cancer: Machine Learning-Augmented Propensity Score Mortality and Cost Analysis in over 30 Million Patients.” Cardio-Oncology (London, England) 7 (1): 25. doi:10.1186/s40959-021-00111-0.